NCATS STTR Phase II
Funds U.S. small businesses and their nonprofit research partners to continue and expand translational R&D begun in STTR Phase I toward a commercial product.
NCATS STTR Phase II is the continuation grant that follows a successful STTR Phase I award. It funds the expansion of the R&D work initiated in Phase I, with the goal of producing a commercial product, process, or service. Awards are normally $2,095,748 in total costs over a two-year project period. Applications may exceed this amount with prior approval from the NCATS Grants Management Officer.
…
Continuation of research and development from STTR Phase I, within NCATS's translational science mission: drug discovery, diagnostics, medical devices, informatics, and platform technologies. NCATS-specific priorities include rare diseases, toxicology, clinical trial innovation, and translational informatics. Phase II must continue work from a prior Phase I — it is not an entry-level grant.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up